Teneurin-2 inhibitors belong to a class of chemical compounds that have garnered interest in the fields of molecular biology and pharmacology due to their to modulate specific cellular processes. Teneurin-2, a member of the teneurin family of transmembrane proteins, plays a multifaceted role in neuronal development, cell adhesion, and intercellular signaling. These proteins are characterized by their large extracellular domains that contain unique EGF-like repeats and are known for their interactions with various cell surface molecules. Teneurin-2, in particular, is primarily expressed in the nervous system and is involved in processes like axon guidance, synapse formation, and neural circuitry development. Teneurin-2 inhibitors are designed to interact with the active site or binding domain of the Teneurin-2 protein, effectively inhibiting its function and influencing cellular processes dependent on Teneurin-2-mediated cell adhesion and signaling.
Structurally, Teneurin-2 inhibitors are engineered to selectively target the active site or binding domains of Teneurin-2, ensuring high specificity for this particular transmembrane protein. By inhibiting Teneurin-2, these compounds may disrupt its role in mediating cell adhesion, axon guidance, and synaptic interactions, leading to alterations in neural development and circuitry. The study of Teneurin-2 inhibitors is of significant interest to researchers as it provides insights into the regulatory mechanisms governing essential cellular functions related to neural connectivity, neuronal differentiation, and axon pathfinding. This knowledge contributes to our understanding of basic neurobiology and may have implications in various research areas, including neurodevelopmental disorders, synaptic plasticity, and the molecular basis of diseases associated with aberrant neural circuit formation. However, further research is required to fully explore the extent of their applications and their impact on cellular physiology in the context of Teneurin-2-mediated cellular processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Affects Wnt signaling, potentially influencing pathways that regulate Teneurin-2 expression. | ||||||
Cyclopamine | 4449-51-8 | sc-200929 sc-200929A | 1 mg 5 mg | $92.00 $204.00 | 19 | |
Inhibits Hedgehog signaling, which could impact developmental pathways including those regulating Teneurin-2. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $80.00 $212.00 $408.00 | 48 | |
Inhibits TGF-beta signaling, potentially influencing developmental pathways affecting Teneurin-2. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
A MEK inhibitor, might affect MAPK/ERK signaling, potentially influencing Teneurin-2 expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
A PI3K inhibitor, could affect signaling pathways potentially regulating Teneurin-2 expression. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Inhibits mTOR signaling, which might influence developmental and neuronal pathways affecting Teneurin-2. | ||||||
IWP-2 | 686770-61-6 | sc-252928 sc-252928A | 5 mg 25 mg | $94.00 $286.00 | 27 | |
Inhibits Wnt production, potentially affecting pathways that regulate Teneurin-2 expression. | ||||||
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $99.00 $335.00 $836.00 $2099.00 | 47 | |
A gamma-secretase inhibitor, potentially affecting Notch signaling, which might influence Teneurin-2 expression. | ||||||